EN DE
Watch Wanjia Group Holdings Ltd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Wanjia Group Holdings Ltd (0401) fair value: what the stock is really worth

As of Nov 13, 2026: fair value (intrinsic value) of Wanjia Group Holdings Ltd stock HK$0.11, price HK$0.11, upside +2.4%, quality 36 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare HK · ISIN KYG9431A1186

WG Wanjia Group Holdings Ltd logo Thin data Nov 10, 2026

Wanjia Group Holdings Ltd

0401 · HK

Rising price, but the stock is already about fairly priced and weak company: meets 1 of 3 rules.

Get notified free when this changes
Rising price (uptrend) 
Low debt 
Fair value HK$0.1116 · Fairly valued 
Expensive Growth (revenue 5y +7.7 %/yr in HKD) 
Quality 36/100 
Loss-making · -6.0% net margin (TTM) 
Negative free cash flow 
Trails peers (2/10) 
Narrow moat 9/100
Thin data 
Estimate⚠ Thinly traded
Watch Wanjia Group Holdings Ltd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

HK$0.6329 HK$0.0380 Fair Value HK$0.1116 Jun 2018 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range HK$0.0380 – HK$0.6329 · fair‑value band HK$0.0839 – HK$0.1392 · the HK$0.1090 price screens below the HK$0.1116 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). 1 fiscal year is left out: there the valuation rested on only a fraction of the usual models. As of Nov 10, 2026.

Follow Wanjia Group Holdings in your weekly email

Every Wednesday you see whether Wanjia Group Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company offers hemodialysis treatment and consultancy services.

Show moreShow less

It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics.

Wanjia Group Holdings Limited was founded in 2004 and is headquartered in Kowloon, Hong Kong.

Stock analysis

Wanjia Group Holdings Ltd (0401) currently trades at HK$0.1090, while our estimate is HK$0.1116, so the stock looks roughly fairly valued today (gap 2.3%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: HK$0.0839 (bear) to HK$0.1392 (bull), the price of HK$0.1090 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 36/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Wanjia Group Holdings Ltd reported revenue of HK$165M in FY2026 versus HK$155M in FY2022, a compound +1.7%/yr. Reported net income was −HK$9.9M in FY2026.

Key figures

Market cap HK$123M (≈ $15.7M) Micro · P/S ratio 0.69 · Net margin −6.0% · Return on equity −13.0% · Return on assets (EBIT) −13.0% (5-year average) · Operating margin −7.5% · Revenue (TTM) HK$165M · Revenue growth (YoY) +2.2%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 9 out of 100 (medium confidence).

What moves the price

The share trades about 46% below its 52-week high and 45% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at 38% fair-value upside, at 2%, 0401 screens richer than that median.

Fair Value

Bear HK$0.0839 Fair Value HK$0.1116 Bull HK$0.1392
Price HK$0.1090 · Upside +2.4%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 36/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 31
How much profit the company makes from its sales and capital
Quality Growth 18
Are margins and returns getting better?
Cashflow 6
Do the profits arrive as real cash?
Financial strength 70
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 12
How calm the share price moves, does not count
Price momentum 23
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 31
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 29/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+2.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−1.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.7%
Start year 2021 (pandemic). Over 10 years: −18.8% a year
Revenue growth 15 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.1%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−1.8% (2021) → −4.4% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
not computed

Watch 0401, get fair value alerts →

Compare Wanjia Group Holdings Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Distribution · 81 stocks

Beats the industry median on 1/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 36 · Bottom 25%
Fair Value upside +2.4% · Above median
Profitability
Return on assets −7.4% · Bottom 25%
Net margin (12 months) −6.0% · Bottom 25%
Operating margin (12 months) −7.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 2.2% · Below median

Valuation Multiplesvs Medical Distribution median · lower = cheaper

P/B 1.47× · Pricier than median
P/S (12 months) 0.74× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)37 · sector 37
FUTURE (revenue growth)11 · sector 18
PAST (return on equity)0 · sector 25
HEALTH (low debt)100 · sector 96
DIVIDEND (yield)0 · sector 54

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Distribution stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Sinopharm Group 1099 HK$16.67 HK$50.01 +200% vs 0401
Jointown Pharmaceutical Group 600998 ¥5.09 ¥11.56 +127% vs 0401
Shanghai Pharmaceuticals Holding 601607 ¥16.13 ¥35.78 +122% vs 0401
China National Medicines Corporation 600511 ¥28.38 ¥58.47 +106% vs 0401
Guangzhou Baiyunshan Pharmaceutical Holdings 600332 ¥19.35 ¥26.64 +38% vs 0401
Cencora, Inc COR $359.03 $341.58 −5% vs 0401
Henry Schein, Inc HSIC $86.22 $78.69 −9% vs 0401
McKesson Corporation MCK $1,103 $822.74 −25% vs 0401
Galenica AG GALE CHF 91.20 CHF 61.79 −32% vs 0401
Cardinal Health, Inc CAH $281.10 $163.14 −42% vs 0401

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Average Down CalculatorFree calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Wanjia Group Holdings Ltd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Wanjia Group Holdings Ltd Fair Value". https://www.fairvalue-calculator.com/stock/0401

Frequently asked questions

Is Wanjia Group Holdings Ltd (0401) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is HK$0.1116 versus a price of HK$0.1090, about +2% upside (fairly valued).
What is the fair value of 0401?
Our estimate for Wanjia Group Holdings Ltd is HK$0.1116 (as of Nov 10, 2026), built from audited fundamentals. The current price: HK$0.1090.
What is the quality score of 0401?
Wanjia Group Holdings Ltd has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Wanjia Group Holdings Ltd (0401)?
Our calculated price target is the estimate of HK$0.1116 (as of Nov 10, 2026). Cautious scenario HK$0.0839, optimistic scenario HK$0.1392. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Wanjia Group Holdings Ltd stock forecast for 2026?
Our estimate puts fair value at HK$0.1116, about +2% upside versus a price of HK$0.1090 (fairly valued). Cautious scenario HK$0.0839, optimistic scenario HK$0.1392. The calculation is refreshed regularly with new filings.
What is the revenue of Wanjia Group Holdings Ltd (0401)?
Wanjia Group Holdings Ltd reported trailing-twelve-month revenue of about HK$165M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Wanjia Group Holdings Ltd (0401)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Wanjia Group Holdings Ltd it is HK$0.1116 per share (as of Nov 10, 2026), against a price of HK$0.1090.
Is Wanjia Group Holdings Ltd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 0401 trades below its calculated fair value: price HK$0.1090, fair value HK$0.1116, a gap of about +2% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0401?
No. The price is what the market pays today (HK$0.1090); the fair value is what the company's own numbers justify (HK$0.1116). For Wanjia Group Holdings Ltd the two are HK$0.0026 per share apart. That gap is exactly why we show both numbers side by side.
How much is Wanjia Group Holdings Ltd worth?
The market values Wanjia Group Holdings Ltd at about HK$123M (market capitalisation, as of Nov 10, 2026). Per share that is HK$0.1090; our models calculate a fair value of HK$0.1116 per share.
What do the bullish and bearish scenarios say about 0401?
Our models span a range for Wanjia Group Holdings Ltd: cautious scenario HK$0.0839, base HK$0.1116, optimistic HK$0.1392 per share (as of Nov 10, 2026, price HK$0.1090). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Wanjia Group Holdings Ltd (0401)?
Balance-sheet figures for Wanjia Group Holdings Ltd (as of Nov 10, 2026): return on equity −13.0%. They feed the Quality Score of 36/100, which measures business quality independently of the share price.
How far is 0401 from its 52-week high?
Wanjia Group Holdings Ltd trades at HK$0.1090, about 46% below its 52-week high of HK$0.2020 and 45% above the low of HK$0.0751 (as of Nov 13, 2026). Distance from the high says nothing about value: that is what the fair value of HK$0.1116 is for.
Which stocks are comparable to Wanjia Group Holdings Ltd?
From the same area (Healthcare) we also value McKesson Corporation, Cencora, Inc, Cardinal Health, Inc, Henry Schein, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Wanjia Group Holdings Ltd stock attractive at the current price?
The data as of Nov 10, 2026: price HK$0.1090, calculated fair value HK$0.1116 (+2%), Quality Score 36/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1% above its aggregate fair value. Wanjia Group Holdings Ltd currently trades 2% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Wanjia Group Holdings Ltd (0401)?
The closing price on Nov 13, 2026 was HK$0.1090. Our estimate is HK$0.1116, about +2% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Wanjia Group Holdings Ltd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Wanjia Group Holdings Ltd

How large is the market capitalisation of Wanjia Group Holdings Ltd (0401)?
The market capitalisation of Wanjia Group Holdings Ltd is HK$123M (≈ $15.7M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Wanjia Group Holdings Ltd (0401)?
The price-to-sales ratio of Wanjia Group Holdings Ltd is 0.69 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Wanjia Group Holdings Ltd (0401)?
The net margin of Wanjia Group Holdings Ltd is −6.0% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Wanjia Group Holdings Ltd (0401)?
The return on equity (ROE) of Wanjia Group Holdings Ltd is −13.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Wanjia Group Holdings Ltd (0401)?
On an EBIT basis the return on assets of Wanjia Group Holdings Ltd is −13.0% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Wanjia Group Holdings Ltd (0401)?
The operating margin of Wanjia Group Holdings Ltd is −7.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Wanjia Group Holdings Ltd (0401)?
Revenue at Wanjia Group Holdings Ltd is growing 2.2% versus a year earlier (3y avg −1.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Wanjia Group Holdings Ltd (0401) generate?
The free cash flow of Wanjia Group Holdings Ltd is −HK$9.0M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Wanjia Group Holdings Ltd (0401) hold?
Wanjia Group Holdings Ltd holds more cash than debt, HK$20.8M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Wanjia Group Holdings Ltd in the live analysis

One click puts Wanjia Group Holdings Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.